JP2017061453A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017061453A5 JP2017061453A5 JP2016190522A JP2016190522A JP2017061453A5 JP 2017061453 A5 JP2017061453 A5 JP 2017061453A5 JP 2016190522 A JP2016190522 A JP 2016190522A JP 2016190522 A JP2016190522 A JP 2016190522A JP 2017061453 A5 JP2017061453 A5 JP 2017061453A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administration
- composition according
- relaxin
- heart failure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12788908P | 2008-05-16 | 2008-05-16 | |
| US61/127,889 | 2008-05-16 | ||
| US19054508P | 2008-08-28 | 2008-08-28 | |
| US61/190,545 | 2008-08-28 | ||
| US20124008P | 2008-12-08 | 2008-12-08 | |
| US61/201,240 | 2008-12-08 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014129744A Division JP2014237648A (ja) | 2008-05-16 | 2014-06-25 | 慢性心不全の治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017061453A JP2017061453A (ja) | 2017-03-30 |
| JP2017061453A5 true JP2017061453A5 (https=) | 2017-07-13 |
Family
ID=41319370
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509781A Withdrawn JP2011520917A (ja) | 2008-05-16 | 2009-05-15 | 慢性心不全の治療方法 |
| JP2014129744A Withdrawn JP2014237648A (ja) | 2008-05-16 | 2014-06-25 | 慢性心不全の治療方法 |
| JP2016190522A Pending JP2017061453A (ja) | 2008-05-16 | 2016-09-29 | 慢性心不全の治療方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509781A Withdrawn JP2011520917A (ja) | 2008-05-16 | 2009-05-15 | 慢性心不全の治療方法 |
| JP2014129744A Withdrawn JP2014237648A (ja) | 2008-05-16 | 2014-06-25 | 慢性心不全の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20110144019A1 (https=) |
| EP (2) | EP3150219A1 (https=) |
| JP (3) | JP2011520917A (https=) |
| CN (2) | CN102026649A (https=) |
| AU (1) | AU2009246112B2 (https=) |
| BR (1) | BRPI0912559A2 (https=) |
| CA (1) | CA2724535A1 (https=) |
| MX (2) | MX2010012502A (https=) |
| RU (1) | RU2512933C2 (https=) |
| WO (1) | WO2009140657A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102036679A (zh) | 2008-05-16 | 2011-04-27 | 科尔泰拉公司 | 用松弛素治疗与急性心力衰竭相关的呼吸困难 |
| BR112012022654A2 (pt) * | 2010-03-10 | 2016-11-01 | Univ Florida | modulação de aquaporinas com relaxina |
| WO2012072681A1 (en) * | 2010-12-01 | 2012-06-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Diagnostic and treatment of chronic heart failure |
| JP2014529293A (ja) * | 2011-07-08 | 2014-11-06 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | レラキシンを放出する融合タンパク質およびその使用 |
| JP6276690B2 (ja) * | 2011-08-04 | 2018-02-07 | ファリス バイオテック ゲーエムベーハー | ヒトリラキシン−２を調製する方法 |
| US10493131B2 (en) | 2011-08-31 | 2019-12-03 | University Of Florida Research Foundation, Incorporated | Materials and methods for modulating activity of bone marrow derived cells |
| US20140364334A1 (en) * | 2011-12-21 | 2014-12-11 | Nuclea Biotechnologies, Inc. | Congestive heart failure biomarkers |
| CN108310396B (zh) | 2012-02-14 | 2022-07-15 | 加利福尼亚大学董事会 | 用于心血管疾病和其它病况的旁分泌基因的全身性递送和受调节的表达 |
| US20140213520A1 (en) * | 2013-01-25 | 2014-07-31 | Cardiorentis Ltd. | Methods of treating cardiovascular indications |
| MX2016005545A (es) * | 2013-11-07 | 2016-10-03 | Shanghai hengrui pharmaceutical co ltd | Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo. |
| US10500227B2 (en) * | 2014-12-03 | 2019-12-10 | University Of Cincinnati | Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease |
| WO2017100540A2 (en) | 2015-12-09 | 2017-06-15 | The California Institute For Biomedical Research | Relaxin immunoglobulin fusion proteins and methods of use |
| CN110637027B (zh) | 2017-02-08 | 2024-08-30 | 百时美施贵宝公司 | 包含药代动力学增强子的修饰的松弛素多肽及其用途 |
| CN107335051A (zh) * | 2017-08-18 | 2017-11-10 | 温州医科大学附属第医院 | 一种保护慢性心衰肾功能的药物组合物 |
| US20220008508A1 (en) * | 2018-11-20 | 2022-01-13 | Universität Heidelberg | Relaxin receptor 1 for use in treatment and prevention of heart failure |
| AU2020382102B2 (en) | 2019-11-16 | 2026-02-26 | Relaxera Pharmazeutische Gmbh & Co. Kg | Medical composition for treating cardiac wasting and cachexia |
| CN116406297A (zh) * | 2020-08-05 | 2023-07-07 | 阿斯克肋匹奥生物制药公司 | 治疗心脏疾患和充血性心力衰竭以及施用aav载体的方法 |
| RU2748529C1 (ru) * | 2020-09-01 | 2021-05-26 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр кардиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ кардиологии" Минздрава России) | Способ определения этиологии хронической сердечной недостаточности |
| TW202438534A (zh) * | 2022-12-09 | 2024-10-01 | 瑞典商阿斯特捷利康公司 | 使用異二聚物鬆弛素融合體的給藥方案 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023321A (en) | 1982-12-13 | 1991-06-11 | Howard Florey Institute Of Experimental Physiology & Medicine | Molecular cloning and characterization of a further gene sequence coding for human relaxin |
| US5166191A (en) * | 1991-08-19 | 1992-11-24 | Genentech, Inc. | Use of relaxin in cardiovascular therapy |
| EP0707650B1 (en) | 1993-06-21 | 2003-05-21 | Genentech, Inc. | Process for producing human relaxin |
| US5811395A (en) | 1995-06-07 | 1998-09-22 | Medical University Of South Carolina | Relaxin analogs and derivatives methods and uses thereof |
| RU2213559C2 (ru) * | 2000-01-26 | 2003-10-10 | Тюменская государственная медицинская академия | Способ лечения больных хронической сердечной недостаточностью на фоне ишемической болезни сердца |
| DE10155843A1 (de) * | 2000-11-16 | 2003-01-30 | Immundiagnostik Ag | Verfahren zur Prognose und Diagnose von Herzinsuffizienz |
| US20050113286A1 (en) * | 2002-03-18 | 2005-05-26 | Schreiner George F. | Methods for treating congestive heart failure |
| CN1968717B (zh) * | 2004-03-30 | 2013-08-21 | 延世大学教产学协力团 | 含有松弛素基因的基因送递系统和使用松弛素的药物组合物 |
| US20080077025A1 (en) * | 2005-07-11 | 2008-03-27 | Leticia Delgado-Herrera | Methods for determining how to treat congestive heart failure |
| US8492329B2 (en) | 2007-07-12 | 2013-07-23 | Compugen Ltd. | Bioactive peptides and methods of using same |
| CN102036679A (zh) * | 2008-05-16 | 2011-04-27 | 科尔泰拉公司 | 用松弛素治疗与急性心力衰竭相关的呼吸困难 |
-
2009
- 2009-05-15 JP JP2011509781A patent/JP2011520917A/ja not_active Withdrawn
- 2009-05-15 EP EP16174665.6A patent/EP3150219A1/en not_active Withdrawn
- 2009-05-15 CN CN2009801176516A patent/CN102026649A/zh active Pending
- 2009-05-15 CA CA2724535A patent/CA2724535A1/en not_active Abandoned
- 2009-05-15 RU RU2010151470/14A patent/RU2512933C2/ru not_active IP Right Cessation
- 2009-05-15 MX MX2010012502A patent/MX2010012502A/es active IP Right Grant
- 2009-05-15 AU AU2009246112A patent/AU2009246112B2/en not_active Ceased
- 2009-05-15 MX MX2012010249A patent/MX336145B/es unknown
- 2009-05-15 BR BRPI0912559A patent/BRPI0912559A2/pt not_active Application Discontinuation
- 2009-05-15 EP EP09747738A patent/EP2288366A4/en not_active Ceased
- 2009-05-15 CN CN201510202983.1A patent/CN104815319A/zh active Pending
- 2009-05-15 US US12/992,667 patent/US20110144019A1/en not_active Abandoned
- 2009-05-15 WO PCT/US2009/044247 patent/WO2009140657A2/en not_active Ceased
-
2013
- 2013-07-11 US US13/939,648 patent/US20140005112A1/en not_active Abandoned
-
2014
- 2014-06-25 JP JP2014129744A patent/JP2014237648A/ja not_active Withdrawn
-
2016
- 2016-04-25 US US15/137,054 patent/US20160287672A1/en not_active Abandoned
- 2016-09-29 JP JP2016190522A patent/JP2017061453A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017061453A5 (https=) | ||
| Krell et al. | Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure | |
| den Uil et al. | Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial | |
| JP2011520917A5 (https=) | ||
| Szczepańska-Sadowska | Hemodynamic effects of moderate increase of the plasma vasopressin level in conscious dogs | |
| López-Rivera et al. | Treatment of hypertensive cardiogenic edema with intravenous high-dose nitroglycerin in a patient presenting with signs of respiratory failure: a case report and review of the literature | |
| Simsic et al. | Perioperative effects and safety of nesiritide following cardiac surgery in children | |
| Mills et al. | “BNP” for heart failure: role of nesiritide in cardiovascular therapeutics | |
| JP2016505065A5 (https=) | ||
| Zineh et al. | The evolving role of nesiritide in advanced or decompensated heart failure | |
| Pensado et al. | Haemodynamic effects of propofol during coronary artery bypass surgery | |
| Sasaoka et al. | Low dose carperitide (alpha-hANP) administration is effective for preventing worsening renal function (WRF) and long-term renal protection | |
| Aundhakar et al. | Cardiorenal syndrome: Resistant to diuretics, sensitive to ultraflitration | |
| Piras | Hypovolemic shock | |
| Rajapreyar et al. | Novel pharmacotherapies for heart failure | |
| PATRO et al. | COMPARISON OF VASOPRESSIN AND PHENYLEPHRINE IN TREATMENT OF DOPAMINE RESISTANT SEPTIC SHOCK–A RANDOMISED CONTROL TRIAL | |
| Teerlink et al. | Levosimendan reduces length of initial hospital stay: the REVIVE II study | |
| Silver et al. | Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of acutely decompensated heart failure | |
| Lee et al. | Forward blood flow provoked by changing intravascular pressure using an extracorporeal circulation during cardiopulmonary resuscitation. | |
| Wang et al. | Intravenous infusion of CXL-1020, a novel nitroxyl (HNO) donor, improves left ventricular systolic and diastolic function in dogs with advanced heart failure | |
| Kassar et al. | A Stab in the Heart: Scimitar Pulmonary Venous Anomaly Complicating a Case of Cardiogenic Shock | |
| Jennings et al. | Effect of 1 year's therapy in essential hypertension on systemic haemodynamics studied before and after ‘total’autonomic blockade | |
| Janwanishstaporn et al. | The Relationship between LVEF and Cardiovascular Outcomes Following Hospitalization for Heart failure: Insights from the RELAX-AHF-2 Trial | |
| Wittebole et al. | High-dose insulin therapy in a case of subarachnoid hemorrhage-related severe cardiodepression with ischemic-like electrocardiographic changes | |
| Solimando et al. | Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach |